Symbols / NDRA $3.30 -4.90%
NDRA Chart
About
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 4.94M |
| Enterprise Value | 3.58M | Income | -8.01M | Sales | — |
| Book/sh | 0.22 | Cash/sh | 0.68 | Dividend Yield | — |
| Payout | 0.00% | Employees | 21 | IPO | — |
| P/E | 0.17 | Forward P/E | -0.71 | PEG | — |
| P/S | — | P/B | 15.14 | P/C | — |
| EV/EBITDA | -0.43 | EV/Sales | — | Quick Ratio | 0.99 |
| Current Ratio | 1.31 | Debt/Eq | 306.53 | LT Debt/Eq | — |
| EPS (ttm) | 19.52 | EPS next Y | -4.62 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-14 16:00 | ROA | -101.97% |
| ROE | -236.34% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.50M |
| Shs Float | 1.10M | Short Float | 14.12% | Short Ratio | 0.72 |
| Short Interest | — | 52W High | 11.96 | 52W Low | 2.90 |
| Beta | -0.11 | Avg Volume | 111.75K | Volume | 11.50K |
| Target Price | $30.00 | Recom | None | Prev Close | $3.47 |
| Price | $3.30 | Change | -4.90% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$30.00
Mean price target
2. Current target
$3.30
Latest analyst target
3. DCF / Fair value
$-53.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.30
Low
$30.00
High
$30.00
Mean
$30.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-08 | main | Ascendiant Capital | Buy → Buy | $30 |
| 2025-09-22 | main | Ascendiant Capital | Buy → Buy | $38 |
| 2025-05-30 | main | Ascendiant Capital | Buy → Buy | $46 |
| 2025-04-21 | main | Ascendiant Capital | Buy → Buy | $50 |
| 2024-06-07 | main | Ascendiant Capital | Buy → Buy | $8 |
| 2023-03-31 | reit | HC Wainwright & Co. | — → Buy | $9 |
- ENDRA Life Sciences (NDRA) CFO awarded 13,461 restricted stock units - Stock Titan Wed, 04 Mar 2026 08
- What’s Driving The Rally In NDRA Stock Today? - Stocktwits Mon, 13 Oct 2025 14
- 5 Stocks Under $5 to Watch Now: OBAI, NDRA, RIME, VTIX, OPEN - Barchart ue, 17 Feb 2026 08
- New Analyst Forecast: $NDRA Given $30 Price Target - Quiver Quantitative Mon, 08 Dec 2025 08
- NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - Zacks Investment Research ue, 03 Mar 2026 08
- [Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan hu, 05 Mar 2026 02
- ENDRA Life Sciences stock soars after securing $4.9M for crypto strategy - Investing.com Mon, 13 Oct 2025 07
- $5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now! - FinancialContent Sun, 25 Jan 2026 08
- ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca - Business Wire Mon, 13 Oct 2025 07
- Why Is ENDRA Life Sciences Stock Soaring Monday? - ENDRA Life Sciences (NASDAQ:NDRA) - Benzinga Mon, 13 Oct 2025 07
- Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now! - openPR.com hu, 26 Feb 2026 08
- NDRA Stock Price Jumps: What’s Next? - timothysykes.com Mon, 13 Oct 2025 07
- Device targets MRI-like liver fat tests for 2B MASLD patients - Stock Titan hu, 26 Feb 2026 08
- ENDRA Life Sciences stock falls after liver device study results - Investing.com hu, 04 Dec 2025 08
- ENDRA Life Sciences raises $4.9 million to launch cryptocurrency treasury - Investing.com Mon, 13 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 26921 | — | — | Stock Award(Grant) at price 0.00 per share. | TOKMAN ALEXANDER Y | Chief Executive Officer | — | 2026-03-02 00:00:00 | D |
| 1 | 13461 | — | — | Stock Award(Grant) at price 0.00 per share. | JACROUX RICHARD | Chief Financial Officer | — | 2026-03-02 00:00:00 | D |
| 2 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2026-01-21 00:00:00 | D |
| 3 | 75000 | — | — | Stock Award(Grant) at price 0.00 per share. | TOKMAN ALEXANDER Y | Chief Executive Officer | — | 2026-01-21 00:00:00 | D |
| 4 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | HARSH MICHAEL JOHN | Director | — | 2026-01-21 00:00:00 | D |
| 5 | 60324 | — | — | Stock Award(Grant) at price 0.00 per share. | BASENESE LOUIS J. | Director | — | 2026-01-21 00:00:00 | D |
| 6 | 20000 | — | — | Stock Award(Grant) at price 0.00 per share. | JACROUX RICHARD | Chief Financial Officer | — | 2026-01-21 00:00:00 | D |
| 7 | 70822 | 500003 | — | Stock Award(Grant) at price 7.06 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2025-10-10 00:00:00 | D |
| 8 | 5384 | — | — | Stock Award(Grant) at price 0.00 per share. | DIGIANDOMENICO ANTHONY | Director | — | 2025-06-11 00:00:00 | D |
| 9 | 5384 | — | — | Stock Award(Grant) at price 0.00 per share. | HARSH MICHAEL JOHN | Director | — | 2025-06-11 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -9.81M | -10.25M | -12.92M | -11.58M |
| TotalUnusualItems | -799.28K | 0.00 | 308.60K | |
| TotalUnusualItemsExcludingGoodwill | -799.28K | 0.00 | 308.60K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -11.51M | -10.06M | -13.18M | -11.23M |
| ReconciledDepreciation | 206.17K | 275.45K | 234.26K | 224.41K |
| EBITDA | -10.61M | -10.25M | -12.92M | -11.27M |
| EBIT | -10.82M | -10.52M | -13.16M | -11.50M |
| NetInterestIncome | -7.32M | 0.00 | ||
| InterestExpense | 0.00 | |||
| NormalizedIncome | -10.71M | -10.06M | -13.18M | -11.54M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -11.51M | -10.06M | -13.18M | -11.23M |
| TotalExpenses | 10.82M | 10.52M | 13.16M | 11.50M |
| TotalOperatingIncomeAsReported | -10.82M | -10.52M | -13.16M | -11.50M |
| DilutedAverageShares | 202.11K | 3.64K | 1.65K | 1.17K |
| BasicAverageShares | 202.11K | 3.64K | 1.65K | 1.17K |
| DilutedEPS | -56.94 | -2.77K | -7.98K | -9.80K |
| BasicEPS | -56.94 | -2.77K | -7.98K | -9.80K |
| DilutedNIAvailtoComStockholders | -11.51M | -10.06M | -13.18M | -11.35M |
| NetIncomeCommonStockholders | -11.51M | -10.06M | -13.18M | -11.35M |
| OtherunderPreferredStockDividend | 0.00 | 121.07K | ||
| NetIncome | -11.51M | -10.06M | -13.18M | -11.23M |
| NetIncomeIncludingNoncontrollingInterests | -11.51M | -10.06M | -13.18M | -11.23M |
| NetIncomeContinuousOperations | -11.51M | -10.06M | -13.18M | -11.23M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -11.51M | -10.06M | -13.18M | -11.23M |
| OtherIncomeExpense | -690.80K | 460.49K | -21.53K | 267.06K |
| OtherNonOperatingIncomeExpenses | 108.48K | 460.49K | -21.53K | -41.55K |
| SpecialIncomeCharges | 0.00 | 308.60K | ||
| OtherSpecialCharges | -308.60K | |||
| GainOnSaleOfSecurity | -799.28K | |||
| NetNonOperatingInterestIncomeExpense | -7.32M | 0.00 | ||
| TotalOtherFinanceCost | 7.32M | |||
| InterestExpenseNonOperating | 0.00 | |||
| OperatingIncome | -10.82M | -10.52M | -13.16M | -11.50M |
| OperatingExpense | 10.82M | 10.52M | 13.16M | 11.50M |
| ResearchAndDevelopment | 3.19M | 5.00M | 6.55M | 5.48M |
| SellingGeneralAndAdministration | 7.63M | 5.52M | 6.60M | 6.02M |
| SellingAndMarketingExpense | 571.04K | 820.55K | 1.43M | 1.08M |
| GeneralAndAdministrativeExpense | 7.06M | 4.70M | 5.17M | 4.94M |
| OtherGandA | 7.06M | 4.70M | 5.17M | 4.94M |
| GrossProfit | 0.00 | |||
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2022-12-31 | 2021-12-31 | ||
|---|---|---|---|---|
| PreferredSharesNumber | 141.00 | 141.00 | ||
| OrdinarySharesNumber | 536.91K | 5.94K | 1.81K | 1.26K |
| ShareIssued | 536.91K | 5.94K | 1.81K | 1.26K |
| TotalDebt | 584.42K | 394.40K | 546.63K | 678.96K |
| TangibleBookValue | 2.56M | 5.66M | 7.20M | 10.78M |
| InvestedCapital | 2.56M | 5.69M | 7.23M | 10.81M |
| WorkingCapital | 2.83M | 2.13M | 3.68M | 10.55M |
| NetTangibleAssets | 2.56M | 5.66M | 7.20M | 10.78M |
| CapitalLeaseObligations | 584.42K | 365.92K | 518.15K | 650.48K |
| CommonStockEquity | 2.56M | 5.66M | 7.20M | 10.78M |
| PreferredStockEquity | 1.00 | 1.00 | 1.00 | |
| TotalCapitalization | 2.56M | 5.66M | 7.20M | 10.81M |
| TotalEquityGrossMinorityInterest | 2.56M | 5.66M | 7.20M | 10.78M |
| StockholdersEquity | 2.56M | 5.66M | 7.20M | 10.78M |
| OtherEquityInterest | 5.23K | 6.07K | 13.86K | |
| RetainedEarnings | -103.44M | -91.93M | -81.87M | -68.69M |
| AdditionalPaidInCapital | 106.00M | 97.58M | 89.07M | 79.46M |
| CapitalStock | 53.00 | 2.00 | 318.00 | 213.00 |
| CommonStock | 53.00 | 1.00 | 317.00 | 212.00 |
| PreferredStock | 0.00 | 1.00 | 1.00 | 1.00 |
| TotalLiabilitiesNetMinorityInterest | 1.89M | 1.10M | 2.07M | 2.09M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.29M | 192.06K | 365.92K | 546.63K |
| DerivativeProductLiabilities | 799.28K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 487.48K | 192.06K | 365.92K | 546.63K |
| LongTermCapitalLeaseObligation | 487.48K | 192.06K | 365.92K | 518.15K |
| LongTermDebt | 28.48K | |||
| CurrentLiabilities | 605.23K | 903.10K | 1.70M | 1.54M |
| CurrentDebtAndCapitalLeaseObligation | 96.94K | 202.34K | 180.71K | 132.33K |
| CurrentCapitalLeaseObligation | 96.94K | 173.86K | 152.23K | 132.33K |
| CurrentDebt | 28.48K | 28.48K | ||
| OtherCurrentBorrowings | 28.48K | 28.48K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 5.75K | 41.27K | 689.49K | 401.79K |
| PayablesAndAccruedExpenses | 502.54K | 659.49K | 833.52K | 1.01M |
| CurrentAccruedExpenses | 232.86K | 299.08K | 219.56K | 218.59K |
| Payables | 269.68K | 360.40K | 613.96K | 791.05K |
| AccountsPayable | 269.68K | 360.40K | 613.96K | 791.05K |
| TotalAssets | 4.45M | 6.75M | 9.27M | 12.87M |
| TotalNonCurrentAssets | 1.02M | 3.72M | 3.89M | 780.53K |
| OtherNonCurrentAssets | 5.99K | 2.63M | 2.65M | 5.99K |
| NonCurrentPrepaidAssets | 365.42K | 626.61K | 502.58K | |
| NetPPE | 647.29K | 465.87K | 741.47K | 774.54K |
| AccumulatedDepreciation | -635.82K | -600.40K | -643.68K | -581.80K |
| GrossPPE | 1.28M | 1.07M | 1.39M | 1.36M |
| ConstructionInProgress | 125.15K | 125.15K | 140.62K | 107.68K |
| OtherProperties | 578.01K | 354.09K | 505.82K | 643.41K |
| Properties | 579.95K | 587.03K | 738.72K | 605.25K |
| CurrentAssets | 3.43M | 3.03M | 5.38M | 12.09M |
| PrepaidAssets | 204.19K | 198.91K | 490.30K | 1.35M |
| Inventory | 2.64M | 1.28M | ||
| RawMaterials | 1.28M | |||
| CashCashEquivalentsAndShortTermInvestments | 3.23M | 2.83M | 4.89M | 9.46M |
| CashAndCashEquivalents | 3.23M | 2.83M | 4.89M | 9.46M |
| CashFinancial | 3.23M | 2.83M | 4.89M | 9.46M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -7.42M | -9.58M | -12.97M | -11.17M |
| RepaymentOfDebt | -28.48K | |||
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 1.15M | 6.48M | 8.40M | 10.62M |
| CapitalExpenditure | -16.00K | -33.88K | -202.58K | -45.00K |
| InterestPaidSupplementalData | 31.91K | 44.98K | 59.11K | 57.66K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 3.23M | 2.83M | 4.89M | 9.46M |
| BeginningCashPosition | 2.83M | 4.89M | 9.46M | 7.23M |
| ChangesInCash | 395.57K | -2.06M | -4.57M | 2.23M |
| FinancingCashFlow | 7.81M | 7.52M | 8.40M | 13.40M |
| CashFlowFromContinuingFinancingActivities | 7.81M | 7.52M | 8.40M | 13.40M |
| NetOtherFinancingCharges | 1.00 | |||
| ProceedsFromStockOptionExercised | 6.69M | 1.03M | 0.00 | 2.79M |
| NetCommonStockIssuance | 1.15M | 6.48M | 8.40M | 10.62M |
| CommonStockIssuance | 1.15M | 6.48M | 8.40M | 10.62M |
| NetIssuancePaymentsOfDebt | -28.48K | 0.00 | ||
| NetShortTermDebtIssuance | -28.48K | |||
| ShortTermDebtPayments | -28.48K | |||
| NetLongTermDebtIssuance | -28.48K | 0.00 | ||
| LongTermDebtPayments | -28.48K | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -12.80K | -24.72K | -202.58K | -45.00K |
| CashFlowFromContinuingInvestingActivities | -12.80K | -24.72K | -202.58K | -45.00K |
| NetPPEPurchaseAndSale | -12.80K | -24.72K | -202.58K | -45.00K |
| SaleOfPPE | 3.20K | 9.16K | 0.00 | |
| PurchaseOfPPE | -16.00K | -33.88K | -202.58K | -45.00K |
| OperatingCashFlow | -7.40M | -9.55M | -12.77M | -11.12M |
| CashFlowFromContinuingOperatingActivities | -7.40M | -9.55M | -12.77M | -11.12M |
| ChangeInWorkingCapital | 134.08K | -923.32K | -1.03M | -1.26M |
| ChangeInOtherCurrentLiabilities | -158.70K | -152.23K | -132.33K | -100.34K |
| ChangeInOtherCurrentAssets | 0.00 | |||
| ChangeInPayablesAndAccruedExpense | -198.87K | -822.26K | 111.58K | 491.10K |
| ChangeInPrepaidAssets | 255.91K | 167.36K | 355.13K | -957.20K |
| ChangeInInventory | 235.73K | -116.19K | -1.36M | -694.96K |
| OtherNonCashItems | -1.00 | |||
| StockBasedCompensation | 571.92K | 996.43K | 1.20M | 1.44M |
| ProvisionandWriteOffofAssets | 2.39M | 138.04K | 0.00 | |
| AssetImpairmentCharge | 8.81K | 24.87K | 1.39K | 9.87K |
| DepreciationAmortizationDepletion | 206.17K | 275.45K | 234.26K | 224.41K |
| DepreciationAndAmortization | 206.17K | 275.45K | 234.26K | 224.41K |
| Depreciation | 206.17K | 275.45K | 234.26K | 224.41K |
| OperatingGainsLosses | 799.28K | -308.60K | ||
| GainLossOnInvestmentSecurities | 799.28K | |||
| NetIncomeFromContinuingOperations | -11.51M | -10.06M | -13.18M | -11.23M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NDRA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|